Phase II trial of 6-thioguanine in advanced renal cell carcinoma - An Illinois Cancer Center study

Daniel H. Shevrin*, Lary J. Kilton, Thomas E. Lad, Michael Mullane, Ben Esparaz, Richard Knop, James Egner, Patricia Johnson, Richard Blough, Suzanne French, Al B. Benson

*Corresponding author for this work

Research output: Contribution to journalArticle

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)345-346
Number of pages2
JournalInvestigational New Drugs
Volume12
Issue number4
DOIs
StatePublished - Dec 1 1994

Keywords

  • 6-thioguanine
  • phase II
  • renal cell cancer

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Shevrin, D. H., Kilton, L. J., Lad, T. E., Mullane, M., Esparaz, B., Knop, R., Egner, J., Johnson, P., Blough, R., French, S., & Benson, A. B. (1994). Phase II trial of 6-thioguanine in advanced renal cell carcinoma - An Illinois Cancer Center study. Investigational New Drugs, 12(4), 345-346. https://doi.org/10.1007/BF00873053